Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 14
Submit an article Journal homepage
87
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Global methylation status of LINE-1 in pediatric myelodysplastic syndrome: a predictive biomarker of prognosis?

Viviane Lamim Lovatela Cytogenetic Laboratory, Bone Marrow Transplantation Center (CEMO), National Cancer Institute (INCA), Rio de Janeiro, BrazilORCID Iconhttps://orcid.org/0000-0001-8493-5855View further author information
ORCID Icon,
Eliane Ferreira Rodriguesa Cytogenetic Laboratory, Bone Marrow Transplantation Center (CEMO), National Cancer Institute (INCA), Rio de Janeiro, BrazilORCID Iconhttps://orcid.org/0000-0003-0419-567XView further author information
ORCID Icon,
Beatriz Ferreira da Silvaa Cytogenetic Laboratory, Bone Marrow Transplantation Center (CEMO), National Cancer Institute (INCA), Rio de Janeiro, BrazilORCID Iconhttps://orcid.org/0000-0003-4375-9300View further author information
ORCID Icon,
Cecilia de Souza Fernandezb Mathematical and Statistical Institute of Federal Fluminense University (UFF), Niterói, BrazilORCID Iconhttps://orcid.org/0000-0001-6410-5117View further author information
ORCID Icon,
Elaine Sobral da Costac Pediatrics Department, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, BrazilORCID Iconhttps://orcid.org/0000-0002-5340-5816View further author information
ORCID Icon,
Eliana Abdelhaya Cytogenetic Laboratory, Bone Marrow Transplantation Center (CEMO), National Cancer Institute (INCA), Rio de Janeiro, BrazilORCID Iconhttps://orcid.org/0000-0001-5166-0832View further author information
ORCID Icon,
Sheila Coelho Soares Limad Molecular Carcinogenesis Program, National Cancer Institute (INCA), Rio de Janeiro, BrazilORCID Iconhttps://orcid.org/0000-0002-6742-3708View further author information
ORCID Icon &
Teresa de Souza Fernandeza Cytogenetic Laboratory, Bone Marrow Transplantation Center (CEMO), National Cancer Institute (INCA), Rio de Janeiro, BrazilCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1299-4666View further author information
ORCID Icon show all
Pages 3484-3487 | Received 24 Mar 2022, Accepted 13 Aug 2022, Published online: 07 Sep 2022

References

  • Hasle H. Myelodysplastic and myeloproliferative disorders of childhood. Hematology Am Soc Hematol Educ Program. 2016;2016(1):598–604.
  • Broske AM, Vockentanz L, Kharazi S, et al. DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction. Nat Genet. 2009;41(11):1207–1215.
  • Lamim Lovatel V, de Souza Fernandez C, Ferreira Rodrigues E, et al. Expression profiles of DNA methylation and demethylation machinery components in pediatric myelodysplastic syndrome: clinical implications. Cancer Manag Res. 2020;12:543–556.
  • Ye F, Li N. Role of p15(INK4B) methylation in patients with myelodysplastic syndromes: a systematic meta-analysis. Clin Lymphoma Myeloma Leuk. 2019;19(6):e259–e265.
  • Calvo X, Nomdedeu M, Navarro A, et al. High levels of global DNA methylation are an independent adverse prognostic factor in a series of 90 patients with de novo myelodysplastic syndrome. Leuk Res. 2014;38(8):874–881.
  • Römermann D, Hasemeier B, Metzig K, et al. Global increase in DNA methylation in patients with myelodysplastic syndrome. Leukemia. 2008;22(10):1954–1956.
  • Qin T, Sotzen J, Rampal RK, et al. Risk of disease progression in low-risk MDS is linked to distinct epigenetic subtypes. Leukemia. 2019;33(11):2753–2757.
  • Poloni A, Goteri G, Zizzi A, et al. Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes. Eur J Haematol. 2013;91(3):219–227.
  • Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene. 2002;21(35):5400–5413.
  • Ehrlich M. DNA hypomethylation in cancer cells. Epigenomics. 2009;1(2):239–259.
  • Miousse IR, Koturbash I. The fine LINE: methylation drawing the cancer landscape. Biomed Res Int. 2015;2015:131547.
  • de Sá Pereira BM, Montalvão-de-Azevedo R, Faria PA, et al. Association between long interspersed nuclear element-1 methylation levels and relapse in Wilms tumors. Clin Epigenetics. 2017;9:128.
  • Poulin M, Zhou JY, Yan L, et al. Pyrosequencing methylation analysis. In: Dumitrescu R, Verma M, editors. Cancer epigenetics for precision medicine: methods in molecular biology. New York (NY): Humana Press; 2018. p. 283–296.
  • Greenberg PL, Tuechler H, Schanz J, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120(12):2454–2465.
  • Kim Y, Jekarl DW, Kim J, et al. Genetic and epigenetic alterations of bone marrow stromal cells in myelodysplastic syndrome and acute myeloid leukemia patients. Stem Cell Res. 2015;14(2):177–184.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.